Provided by Tiger Fintech (Singapore) Pte. Ltd.

CARSGEN-B

23.100
-0.250-1.07%
Volume:1.28M
Turnover:29.58M
Market Cap:13.31B
PE:-14.62
High:24.050
Open:24.000
Low:22.600
Close:23.350
Loading ...

CARsgen Therapeutics Announces Nda Acceptance of Satri-Cel by China's Nmpa

THOMSON REUTERS
·
26 Jun

CARsgen Therapeutics' New Drug Application for Satricabtagene Autoleucel for Advanced Gastric Cancer Accepted by National Medical Products Administration

Reuters
·
26 Jun

CARsgen Therapeutics - Nmpa Accepted New Drug Application for Satricabtagene Autoleucel for Treatment of Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

THOMSON REUTERS
·
26 Jun

CARsgen Therapeutics Announces Presentation of CT071 Clinical Trial Results for Multiple Myeloma at 2025 EHA Congress

Reuters
·
16 Jun

CARsgen Therapeutics Receives Breakthrough Therapy Designation and Priority Review for Satri-cel in Advanced Gastric Cancer Treatment

Reuters
·
02 Jun

CARsgen Therapeutics' Satricabtagene Autoleucel Granted Priority Review by China's NMPA for Advanced Gastric Cancer Therapy

Reuters
·
28 May

CARsgen Therapeutics - Satricabtagene Autoleucel Granted Priority Review by Nmpa

THOMSON REUTERS
·
28 May

CARsgen Therapeutics Holdings Ltd. Conducted Annual General Meeting

Reuters
·
22 May

BUZZ-CARsgen Therapeutics hits nearly 11-week high on share buyback plan

Reuters
·
13 May

BRIEF-Carsgen Therapeutics To Repurchase Shares Not Exceeding 1% Of Total Issued Shares In Open Market

Reuters
·
13 May

CARsgen Therapeutics Completes Buyback of 4,135,500 Shares at HK$24,116,134.85

Reuters
·
13 May

CARsgen Therapeutics - to Repurchase Shares Not Exceeding 1% of Total Issued Shares in Open Market

THOMSON REUTERS
·
13 May

CARsgen Therapeutics Widens Loss in 2024

MT Newswires Live
·
19 Mar

CARsgen Announced 2024 Annual Results

THOMSON REUTERS
·
19 Mar

Press Release: CARsgen Announced 2024 Annual Results

Dow Jones
·
19 Mar

BRIEF-CARsgen Therapeutics Says Net Loss Was Around RMB798 Mln For Year

Reuters
·
18 Mar

Carsgen Therapeutics Posts FY Net Income RMB -798 Mln

Reuters
·
18 Mar

CARsgen Therapeutics Holdings Ltd - Net Loss Was Around RMB798 Mln for Year

THOMSON REUTERS
·
18 Mar

CARsgen Therapeutics Holdings FY Capex RMB 20 Million

THOMSON REUTERS
·
18 Mar

CARsgen's Claudin18.2 CAR-T Therapy Satri-Cel Granted Breakthrough Therapy Designation by the Nmpa

THOMSON REUTERS
·
03 Mar